Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. NBP210396

Novus Biologicals™ PDIA2 Overexpression Lysate
SDP

Catalog No. NBP210396 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP210396 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP210396 Supplier Novus Biologicals™ Supplier No. NBP210396
Only null left
Add to Cart
Add to Cart

Description

The PDI Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.

Specifications

Cell Line The lysate was created in HEK293T cells, using plasmid ID RC215316 and based on accession number NP_684. The protein contains a C-terminal DDK tag.
For Use With (Application) Western Blot
Quantity 0.1 mg
Storage Buffer RIPA buffer
Purity Protein
Test Specificity Homo sapiens PDI, mRNA.
Content And Storage -80°C. Avoid freeze-thaw cycles.
Research Category Cancer, Cellular Markers, ER Markers, Hypoxia
Target PDIA2
Synonym Pancreas-specific protein disulfide isomerase, pancreatic protein disulfide isomerase, PDA2, PDI, PDIp, PDIR, protein disulfide isomerase, pancreatic, protein disulfide isomerase-associated 2, protein disulfide-isomerase A2, Rho GDP dissociation inhibitor gamma
Protein State Native
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.